GGrantIndex
← Leaderboards

Suzanne Elizabeth Lapi

University Of Alabama At Birmingham

$6,151,104
Attributed
$6,454,519
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY201625
$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,454,519 · 8

By mechanism

P01$3,468,259 · 2
R01$1,334,963 · 1
R41$574,808 · 2
P30$457,959 · 1
R21$381,830 · 1
S10$236,700 · 1

Top collaborators

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Image

Research focus

ImageImaging AgentLabelSpecificityPre-ClinicalTherapeutic AgentsAntibodiesClinical TrialsBaseRadioimmunoconjugatePositron-Emission TomographyRadiolabeledMolecular ImagingCgmp ProductionClinical ResearchMalignant NeoplasmsPumpRadionuclide ImagingRadiopharmaceuticalsPre-Clinical ModelClinical ImagingBiodistributionCaveolaeSolid Neoplasm

Grant awards (19)

02 - Experimental Therapeutics$457,959
P30 · FY2025 · CA · contact PI
A novel platform for targeted radiopharmaceuticals for imaging and therapy of ovarian cancer$349,808
R41 · FY2024 · CA · contact PI
Clinical Trials for Imaging and Therapy$1,034,972
P01 · FY2023 · CA · contact PI
Radiochemistry Core$63,751
P01 · FY2023 · CA · contact PI
Clinical Trials for Imaging and Therapy$864,904
P01 · FY2022 · CA · contact PI
Synthra MeIPlus Research with HCN/CO Options and Radchrom Plus for the UAB Cyclotron Facility$236,700
S10 · FY2022 · OD · contact PI
Radiochemistry Core$175,808
P01 · FY2022 · CA · contact PI
Clinical Trials for Imaging and Therapy$444,757
P01 · FY2021 · CA · contact PI
Radiochemistry Core$127,823
P01 · FY2021 · CA · contact PI
Imaging of alterations in SSTR2 expression with histone deacetylase (HDAC) inhibitors treatment for neuroendocrine tumors$381,830
R21 · FY2020 · CA
Clinical Trials for Imaging and Therapy$296,287
P01 · FY2020 · CA · contact PI
Radiochemistry Core$159,701
P01 · FY2020 · CA · contact PI
RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER$326,174
R01 · FY2019 · CA · contact PI
Gallium 68 Tilmanocept for PET Imaging of Atherosclerosis Plaques$225,000
R41 · FY2019 · HL · contact PI
Clinical Trials for Imaging and Therapy$157,931
P01 · FY2019 · CA · contact PI
Radiochemistry Core$142,325
P01 · FY2019 · CA · contact PI
RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER$336,263
R01 · FY2018 · CA · contact PI
RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER$336,263
R01 · FY2017 · CA · contact PI
RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER$336,263
R01 · FY2016 · CA · contact PI